Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurokinin B | 14 | 2022 | 67 | 2.780 |
Why?
|
Luteinizing Hormone | 31 | 2021 | 820 | 2.540 |
Why?
|
Gonadotropin-Releasing Hormone | 25 | 2024 | 1153 | 2.120 |
Why?
|
Sexual Maturation | 16 | 2023 | 260 | 2.040 |
Why?
|
Reproduction | 14 | 2024 | 647 | 1.770 |
Why?
|
Neurosecretory Systems | 6 | 2013 | 221 | 1.430 |
Why?
|
Tachykinins | 3 | 2020 | 77 | 1.300 |
Why?
|
Hypothalamus | 19 | 2024 | 998 | 1.230 |
Why?
|
Dynorphins | 9 | 2022 | 82 | 1.120 |
Why?
|
Columbidae | 3 | 2021 | 40 | 1.090 |
Why?
|
Discrimination Learning | 3 | 2021 | 278 | 0.940 |
Why?
|
Substance P | 7 | 2019 | 333 | 0.840 |
Why?
|
Receptors, Neuropeptide | 7 | 2011 | 105 | 0.840 |
Why?
|
Fertility | 3 | 2020 | 772 | 0.800 |
Why?
|
Dendrimers | 1 | 2022 | 71 | 0.780 |
Why?
|
Receptors, Opioid, kappa | 1 | 2022 | 138 | 0.720 |
Why?
|
Neurons | 15 | 2024 | 9416 | 0.720 |
Why?
|
Puberty | 6 | 2023 | 498 | 0.710 |
Why?
|
Receptors, Neurokinin-1 | 3 | 2017 | 132 | 0.710 |
Why?
|
Estrogens | 5 | 2018 | 1520 | 0.660 |
Why?
|
Receptors, Tachykinin | 1 | 2018 | 25 | 0.660 |
Why?
|
Hot Flashes | 1 | 2022 | 327 | 0.640 |
Why?
|
Gonadotropins | 9 | 2011 | 241 | 0.640 |
Why?
|
Follicle Stimulating Hormone | 11 | 2014 | 724 | 0.630 |
Why?
|
Ventromedial Hypothalamic Nucleus | 1 | 2018 | 46 | 0.620 |
Why?
|
Conditioning, Operant | 1 | 2020 | 308 | 0.620 |
Why?
|
Association Learning | 1 | 2020 | 219 | 0.620 |
Why?
|
Rats, Wistar | 27 | 2014 | 1849 | 0.590 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2018 | 108 | 0.580 |
Why?
|
Tumor Suppressor Proteins | 7 | 2011 | 2804 | 0.580 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2022 | 378 | 0.580 |
Why?
|
Receptors, G-Protein-Coupled | 14 | 2013 | 1244 | 0.560 |
Why?
|
Proteins | 14 | 2010 | 6030 | 0.560 |
Why?
|
Gonadal Steroid Hormones | 7 | 2021 | 701 | 0.500 |
Why?
|
Menopause | 1 | 2022 | 1640 | 0.450 |
Why?
|
Receptors, Neurokinin-3 | 5 | 2014 | 59 | 0.440 |
Why?
|
Sex Differentiation | 2 | 2011 | 73 | 0.410 |
Why?
|
Mice, Knockout | 11 | 2024 | 14396 | 0.390 |
Why?
|
Animals | 64 | 2024 | 167940 | 0.370 |
Why?
|
Receptors, Neurokinin-2 | 3 | 2021 | 24 | 0.340 |
Why?
|
Rats | 32 | 2024 | 23695 | 0.340 |
Why?
|
Neuropeptides | 6 | 2011 | 941 | 0.340 |
Why?
|
Peptide Fragments | 8 | 2014 | 5120 | 0.320 |
Why?
|
Endocrine Glands | 1 | 2007 | 101 | 0.290 |
Why?
|
Protein Precursors | 3 | 2014 | 1135 | 0.290 |
Why?
|
Signal Transduction | 15 | 2024 | 23363 | 0.280 |
Why?
|
Neurotransmitter Agents | 1 | 2011 | 661 | 0.280 |
Why?
|
Heart Diseases | 1 | 2020 | 2809 | 0.280 |
Why?
|
Mice | 26 | 2024 | 81216 | 0.270 |
Why?
|
Pituitary Gland | 6 | 2006 | 637 | 0.270 |
Why?
|
Injections, Intraventricular | 5 | 2009 | 225 | 0.260 |
Why?
|
Puberty, Precocious | 2 | 2020 | 163 | 0.260 |
Why?
|
Feeding Behavior | 1 | 2017 | 3185 | 0.250 |
Why?
|
Liver Abscess | 1 | 2023 | 81 | 0.220 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2007 | 698 | 0.220 |
Why?
|
Peptide Hormones | 4 | 2010 | 132 | 0.220 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1890 | 0.210 |
Why?
|
Oligopeptides | 5 | 2008 | 1188 | 0.200 |
Why?
|
Ovariectomy | 9 | 2010 | 611 | 0.190 |
Why?
|
Mice, Obese | 3 | 2021 | 420 | 0.190 |
Why?
|
Vasomotor System | 1 | 2022 | 207 | 0.190 |
Why?
|
Epothilones | 1 | 2020 | 42 | 0.180 |
Why?
|
Estradiol | 7 | 2014 | 1932 | 0.180 |
Why?
|
Feedback, Physiological | 3 | 2011 | 476 | 0.170 |
Why?
|
Vagina | 2 | 2004 | 842 | 0.170 |
Why?
|
Escherichia coli Infections | 1 | 2023 | 524 | 0.170 |
Why?
|
Sheep | 1 | 2022 | 1441 | 0.160 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 718 | 0.160 |
Why?
|
Disease Models, Animal | 5 | 2022 | 18134 | 0.160 |
Why?
|
Rodentia | 2 | 2013 | 260 | 0.160 |
Why?
|
Animals, Newborn | 7 | 2008 | 2671 | 0.150 |
Why?
|
Receptors, Progesterone | 4 | 2011 | 1122 | 0.150 |
Why?
|
Excitatory Amino Acids | 3 | 2006 | 17 | 0.140 |
Why?
|
Advance Care Planning | 1 | 2024 | 697 | 0.140 |
Why?
|
Ghrelin | 4 | 2013 | 252 | 0.140 |
Why?
|
Tauopathies | 1 | 2020 | 317 | 0.140 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.140 |
Why?
|
Glutamic Acid | 2 | 2013 | 1166 | 0.140 |
Why?
|
Leptin | 5 | 2013 | 1590 | 0.140 |
Why?
|
Receptors, Estrogen | 3 | 2011 | 2202 | 0.130 |
Why?
|
Astrocytes | 1 | 2024 | 1335 | 0.130 |
Why?
|
RNA, Messenger | 10 | 2013 | 12762 | 0.130 |
Why?
|
Hypogonadism | 2 | 2019 | 800 | 0.120 |
Why?
|
Female | 43 | 2024 | 391011 | 0.120 |
Why?
|
Ligands | 6 | 2014 | 3277 | 0.120 |
Why?
|
Microtubules | 1 | 2020 | 1072 | 0.120 |
Why?
|
Energy Metabolism | 4 | 2017 | 2869 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
Pattern Recognition, Visual | 1 | 2020 | 810 | 0.110 |
Why?
|
Buprenorphine | 1 | 2022 | 653 | 0.110 |
Why?
|
Gene Expression | 7 | 2013 | 7592 | 0.110 |
Why?
|
Estrous Cycle | 3 | 2010 | 64 | 0.110 |
Why?
|
Photic Stimulation | 1 | 2020 | 1968 | 0.110 |
Why?
|
Alzheimer Disease | 3 | 2021 | 8551 | 0.110 |
Why?
|
Estrogen Receptor alpha | 3 | 2008 | 580 | 0.110 |
Why?
|
Ovulation | 3 | 2011 | 181 | 0.100 |
Why?
|
Radioimmunoassay | 4 | 2006 | 866 | 0.100 |
Why?
|
Microglia | 1 | 2021 | 1348 | 0.100 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9531 | 0.100 |
Why?
|
Male | 34 | 2024 | 359413 | 0.100 |
Why?
|
Orchiectomy | 3 | 2008 | 470 | 0.100 |
Why?
|
Estrogen Receptor beta | 3 | 2008 | 168 | 0.100 |
Why?
|
Galanin-Like Peptide | 2 | 2011 | 2 | 0.100 |
Why?
|
Sexual Development | 1 | 2011 | 40 | 0.100 |
Why?
|
Mice, Inbred C57BL | 5 | 2023 | 22025 | 0.100 |
Why?
|
Brain | 5 | 2021 | 26912 | 0.090 |
Why?
|
Estrus | 3 | 2006 | 70 | 0.090 |
Why?
|
Frameshift Mutation | 1 | 2013 | 388 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2008 | 1109 | 0.090 |
Why?
|
Testis | 2 | 2004 | 794 | 0.090 |
Why?
|
Ribonucleoproteins | 1 | 2013 | 372 | 0.090 |
Why?
|
Learning | 1 | 2020 | 1733 | 0.090 |
Why?
|
Plaque, Amyloid | 1 | 2014 | 758 | 0.090 |
Why?
|
Neurotensin | 1 | 2009 | 57 | 0.080 |
Why?
|
Aging | 5 | 2014 | 8641 | 0.080 |
Why?
|
Phenols | 3 | 2008 | 513 | 0.080 |
Why?
|
Receptors, Opioid | 1 | 2009 | 145 | 0.080 |
Why?
|
Palliative Care | 1 | 2024 | 3607 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2006 | 10829 | 0.080 |
Why?
|
Peptide YY | 2 | 2006 | 136 | 0.080 |
Why?
|
Sex Factors | 3 | 2018 | 10530 | 0.080 |
Why?
|
Appetite | 1 | 2010 | 247 | 0.080 |
Why?
|
Follicular Phase | 1 | 2008 | 143 | 0.080 |
Why?
|
Gonadal Hormones | 1 | 2007 | 30 | 0.070 |
Why?
|
Humans | 22 | 2024 | 760261 | 0.070 |
Why?
|
Nitric Oxide | 3 | 2006 | 2141 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2017 | 2567 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 788 | 0.070 |
Why?
|
Receptors, Neurotransmitter | 1 | 2006 | 174 | 0.070 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1132 | 0.070 |
Why?
|
Testosterone | 5 | 2012 | 2469 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2020 | 3976 | 0.070 |
Why?
|
Amyloid beta-Peptides | 2 | 2021 | 3839 | 0.070 |
Why?
|
Sex Determination Processes | 1 | 2006 | 59 | 0.060 |
Why?
|
Injections, Intravenous | 2 | 2006 | 1388 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 1066 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2009 | 1900 | 0.060 |
Why?
|
Fasting | 3 | 2006 | 1603 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 4573 | 0.060 |
Why?
|
Globins | 1 | 2006 | 403 | 0.060 |
Why?
|
Models, Neurological | 2 | 2011 | 1758 | 0.060 |
Why?
|
Rats, Zucker | 1 | 2004 | 132 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2874 | 0.060 |
Why?
|
Hormones, Ectopic | 1 | 2004 | 37 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2004 | 56 | 0.060 |
Why?
|
Pregnancy, Animal | 1 | 2005 | 124 | 0.060 |
Why?
|
Castration | 1 | 2004 | 153 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2004 | 413 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2006 | 3601 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2563 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1892 | 0.060 |
Why?
|
Goats | 2 | 2014 | 167 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2024 | 550 | 0.050 |
Why?
|
Insulin | 3 | 2013 | 6592 | 0.050 |
Why?
|
Benzhydryl Compounds | 1 | 2008 | 942 | 0.050 |
Why?
|
Ovary | 1 | 2006 | 959 | 0.050 |
Why?
|
Dinoprostone | 1 | 2024 | 599 | 0.050 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 114 | 0.050 |
Why?
|
Environment | 1 | 2007 | 1118 | 0.050 |
Why?
|
Concept Formation | 1 | 2021 | 159 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11341 | 0.050 |
Why?
|
Hormones | 1 | 2004 | 867 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2023 | 580 | 0.040 |
Why?
|
Tubulin Modulators | 1 | 2020 | 107 | 0.040 |
Why?
|
Axonal Transport | 1 | 2020 | 178 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1426 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 4 | 2020 | 8157 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12281 | 0.040 |
Why?
|
Body Weight | 5 | 2008 | 4613 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1723 | 0.040 |
Why?
|
Malnutrition | 1 | 2005 | 638 | 0.040 |
Why?
|
Time Factors | 6 | 2014 | 40133 | 0.040 |
Why?
|
Models, Biological | 2 | 2011 | 9468 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3784 | 0.030 |
Why?
|
Cues | 1 | 2021 | 867 | 0.030 |
Why?
|
Sex Characteristics | 3 | 2013 | 2627 | 0.030 |
Why?
|
Tissue Distribution | 2 | 2013 | 2262 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2612 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2021 | 790 | 0.030 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11902 | 0.030 |
Why?
|
Eating | 3 | 2008 | 1538 | 0.030 |
Why?
|
Neurokinin A | 1 | 2014 | 32 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11064 | 0.030 |
Why?
|
Food Deprivation | 2 | 2005 | 114 | 0.030 |
Why?
|
Enkephalins | 1 | 2014 | 139 | 0.030 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 582 | 0.030 |
Why?
|
Leydig Cells | 2 | 2004 | 55 | 0.030 |
Why?
|
Hypophysectomy | 2 | 2004 | 114 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13456 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2005 | 2906 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17628 | 0.030 |
Why?
|
Chorionic Gonadotropin | 2 | 2006 | 457 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9590 | 0.030 |
Why?
|
Androgens | 2 | 2012 | 1289 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2012 | 195 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3046 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4223 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4264 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1007 | 0.020 |
Why?
|
Thalamic Nuclei | 1 | 2011 | 111 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2004 | 4938 | 0.020 |
Why?
|
Adamantane | 1 | 2011 | 169 | 0.020 |
Why?
|
Hypothalamus, Middle | 1 | 2009 | 15 | 0.020 |
Why?
|
Median Eminence | 1 | 2009 | 28 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2235 | 0.020 |
Why?
|
Nitriles | 2 | 2006 | 955 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2006 | 7854 | 0.020 |
Why?
|
Genes, fos | 1 | 2009 | 174 | 0.020 |
Why?
|
Dipeptides | 1 | 2011 | 410 | 0.020 |
Why?
|
Naltrexone | 1 | 2011 | 317 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2753 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5784 | 0.020 |
Why?
|
Estrenes | 1 | 2008 | 21 | 0.020 |
Why?
|
Preoptic Area | 1 | 2009 | 132 | 0.020 |
Why?
|
Periodicity | 1 | 2010 | 349 | 0.020 |
Why?
|
Streptozocin | 1 | 2008 | 193 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2494 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2008 | 108 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29950 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 2056 | 0.020 |
Why?
|
Biological Clocks | 1 | 2010 | 316 | 0.020 |
Why?
|
Diestrus | 1 | 2006 | 5 | 0.020 |
Why?
|
Proestrus | 1 | 2006 | 14 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2013 | 995 | 0.020 |
Why?
|
Furans | 1 | 2008 | 199 | 0.020 |
Why?
|
Electrophysiology | 1 | 2010 | 1265 | 0.020 |
Why?
|
Gonadotropins, Equine | 1 | 2006 | 7 | 0.020 |
Why?
|
Photoperiod | 1 | 2007 | 139 | 0.020 |
Why?
|
Growth and Development | 1 | 2006 | 47 | 0.020 |
Why?
|
Pregnancy | 3 | 2021 | 29725 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1697 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7593 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 893 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2797 | 0.020 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2006 | 139 | 0.020 |
Why?
|
Genitalia, Male | 1 | 2006 | 87 | 0.020 |
Why?
|
Appetite Regulation | 1 | 2006 | 84 | 0.020 |
Why?
|
Pituitary Gland, Anterior | 1 | 2006 | 142 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1262 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 4577 | 0.020 |
Why?
|
Propionates | 1 | 2006 | 182 | 0.020 |
Why?
|
Genitalia, Female | 1 | 2006 | 147 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2011 | 1169 | 0.020 |
Why?
|
Sertoli Cells | 1 | 2004 | 50 | 0.010 |
Why?
|
Seminiferous Tubules | 1 | 2004 | 25 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.010 |
Why?
|
Pyrazoles | 2 | 2006 | 1992 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 778 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2716 | 0.010 |
Why?
|
Growth Hormone | 1 | 2006 | 568 | 0.010 |
Why?
|
CHO Cells | 1 | 2006 | 1389 | 0.010 |
Why?
|
Resistin | 1 | 2004 | 172 | 0.010 |
Why?
|
Lactation | 1 | 2006 | 395 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 679 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 2003 | 152 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2006 | 599 | 0.010 |
Why?
|
Injections | 1 | 2006 | 830 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2427 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16543 | 0.010 |
Why?
|
Action Potentials | 1 | 2010 | 1814 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2558 | 0.010 |
Why?
|
Progesterone | 1 | 2006 | 742 | 0.010 |
Why?
|
Cell Communication | 1 | 2009 | 1642 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4717 | 0.010 |
Why?
|
Hippocampus | 1 | 2014 | 3737 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2852 | 0.010 |
Why?
|
Prolactin | 1 | 2003 | 621 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22041 | 0.010 |
Why?
|
PPAR gamma | 1 | 2004 | 484 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12915 | 0.010 |
Why?
|
Thiazolidinediones | 1 | 2004 | 465 | 0.010 |
Why?
|
Organ Specificity | 1 | 2006 | 1955 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15626 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2004 | 977 | 0.010 |
Why?
|
Uterus | 1 | 2003 | 651 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17766 | 0.010 |
Why?
|
Tamoxifen | 1 | 2003 | 963 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12959 | 0.010 |
Why?
|
Child | 2 | 2019 | 79758 | 0.010 |
Why?
|
Neoplasms | 1 | 2007 | 22066 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4409 | 0.010 |
Why?
|
Adipocytes | 1 | 2004 | 1179 | 0.010 |
Why?
|
Adult | 2 | 2023 | 219847 | 0.010 |
Why?
|
Down-Regulation | 1 | 2004 | 2918 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4900 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2696 | 0.010 |
Why?
|
United States | 1 | 2024 | 72363 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2721 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6067 | 0.010 |
Why?
|
Homeostasis | 1 | 2006 | 3305 | 0.010 |
Why?
|
Blood Glucose | 1 | 2008 | 6375 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3451 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 58673 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64947 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 87747 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18415 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42034 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58947 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15827 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2004 | 11480 | 0.000 |
Why?
|
Aged | 1 | 2014 | 168995 | 0.000 |
Why?
|
Concepts
(301)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_